Make - your - own weight - loss drug using an innovative genome editing approach
- Details
- Category: Research
In a study published in Communications Medicine, researchers from The University of Osaka have revealed that a modified genome editing approach to tackle noncommunicable, multifaceted diseases.
Common autoimmune drug may help reverse immunotherapy - induced diabetes
- Details
- Category: Research
The study, published in JCI Insight, identifies a new group of immune cells involved in the development immune checkpoint inhibitor - induced type 1 diabetes and shows that JAK inhibitors,
Cohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
- Details
- Category: Events
Before HPV vaccination among teenage girls started in Denmark, high-risk HPV was found in all cervical cancers. HPV types 16/18 accounted for around three quarters (74%) of cervical cancers.
Researchers discover new way cells protect themselves from damage
- Details
- Category: Research
Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks
- Details
- Category: Research
What's more, these risks were more than twice as high in those normally considered too young to develop either condition - 18 - 64 year olds - the findings indicate.
Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
- Details
- Category: Research
Research opens up new avenue for tuberculosis drug discovery
- Details
- Category: Research
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, is the second largest infectious killer globally after COVID-19 and causes 1.3 million deaths annually.
Aggressive skin cancer driven by mitochondrial processes - existing drugs offer promising treatment path
- Details
- Category: Research
Study highlights major hurdles for multinational clinical trials in Europe
- Details
- Category: Research
New model to find treatments for an aggressive blood cancer
- Details
- Category: Research
In a paper published in Nature Communications a team of researchers led from the University of Birmingham have studied blood cells from patients with a blood cancer called myelodysplastic syndrome disease (MDS).